PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous CELL Carcinoma in Patients Whose Tumor Expressed Programmed Death-Ligand 1 at Combined Positive Score ≥1 in France.
Saved in:
| Title: | PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous CELL Carcinoma in Patients Whose Tumor Expressed Programmed Death-Ligand 1 at Combined Positive Score ≥1 in France. |
|---|---|
| Authors: | Massetti, M.1 (AUTHOR), Even, C.2 (AUTHOR), Geoffrois, L.3 (AUTHOR), Farge, G.4 (AUTHOR), Levy Bachelot, L.4 (AUTHOR), Borse, R.5 (AUTHOR), Chirovsky, D.5 (AUTHOR), Durand-Zaleski, I.6 (AUTHOR) |
| Source: | Value in Health. 2020 Supplement 2, Vol. 23, pS436-S436. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 160979841 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous CELL Carcinoma in Patients Whose Tumor Expressed Programmed Death-Ligand 1 at Combined Positive Score ≥1 in France. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Massetti%2C+M%2E%22">Massetti, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Even%2C+C%2E%22">Even, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Geoffrois%2C+L%2E%22">Geoffrois, L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Farge%2C+G%2E%22">Farge, G.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Levy+Bachelot%2C+L%2E%22">Levy Bachelot, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Borse%2C+R%2E%22">Borse, R.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chirovsky%2C+D%2E%22">Chirovsky, D.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Durand-Zaleski%2C+I%2E%22">Durand-Zaleski, I.</searchLink><relatesTo>6</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Value+in+Health%22">Value in Health</searchLink>. 2020 Supplement 2, Vol. 23, pS436-S436. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160979841 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jval.2020.08.218 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S436 Titles: – TitleFull: PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous CELL Carcinoma in Patients Whose Tumor Expressed Programmed Death-Ligand 1 at Combined Positive Score ≥1 in France. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Massetti, M. – PersonEntity: Name: NameFull: Even, C. – PersonEntity: Name: NameFull: Geoffrois, L. – PersonEntity: Name: NameFull: Farge, G. – PersonEntity: Name: NameFull: Levy Bachelot, L. – PersonEntity: Name: NameFull: Borse, R. – PersonEntity: Name: NameFull: Chirovsky, D. – PersonEntity: Name: NameFull: Durand-Zaleski, I. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 12 Text: 2020 Supplement 2 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 10983015 Numbering: – Type: volume Value: 23 Titles: – TitleFull: Value in Health Type: main |
| ResultId | 1 |
